Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03313999 · ClinicalTrials.gov registry record · NA
Measuring Skin Elasticity in Lymphedema Patients
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03313999: Clinical Trial NA study, sponsored by Beth Israel Deaconess Medical Center.
NCT03313999 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03313999, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This protocol will utilize the lymphedema indentometer, or durometer (a novel, noninvasive piece of equipment that measures skin elasticity), to better characterize disease progression in patients with lymphedema. Beth Israel Deaconess Medical Center patients who undergo treatment of lymphedema will be candidates for this noninvasive test. This device and the data it generates will help understand the incidence of lymphedema at Beth Israel Deaconess Medical Center compared to national data and the outcomes of surgical treatment of lymphedema.
Primary Outcome
Value providing measure for the viscoelastic properties of skin including firmness and mechanical creep.
Interventions
- DEVICE Lymphedema Indentometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-02-18 |
| Est. Completion | 2025-06-02 |
| Phase | NA |
Why NCT03313999 stopped before completion
NCT03313999 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Lymphedema Indentometer is the first listed.
NCT03313999 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03313999 about?
NCT03313999 is a clinical study titled "Measuring Skin Elasticity in Lymphedema Patients". This protocol will utilize the lymphedema indentometer, or durometer (a novel, noninvasive piece of equipment that measures skin elasticity), to better characterize disease progression in patients with lymphedema. Beth Israel Deaconess Medical Center patients who undergo treatment of lymphedema will...
What is the current status of trial NCT03313999?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2018-02-18. Estimated completion is 2025-06-02.
What interventions are being tested in trial NCT03313999?
The interventions under investigation include: Lymphedema Indentometer (DEVICE).
Who is sponsoring clinical trial NCT03313999?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03313999's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI